Sexual activity and function in women more than 2 years after midurethral sling placement Journal Article


Authors: Zyczynski, H. M.; Rickey, L; Dyer, K. Y.; Wilson, T.; Stoddard, A. M.; Gormley, E. A.; Hsu, Y.; Kusek, J. W.; Brubaker, L; Urinary Incontinence Treatment Network
Article Title: Sexual activity and function in women more than 2 years after midurethral sling placement
Abstract: OBJECTIVE: The purpose of this study was to assess prospectively the effects of midurethral sling surgery on sexual function and activity. STUDY DESIGN: Sexual activity and function was assessed in 597 women with stress urinary incontinence who were enrolled in a randomized equivalence trial of retropubic compared with transobturator midurethral slings. Repeated measures analysis of variance was used to assess changes in Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire scores over a 2-year period. RESULTS: Significant, similar improvements in sexual function were seen in both midurethral sling groups. Mean Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire scores increased from 32.8 at baseline to 37.6 at 6 months and 37.3 at 24 months (P .0001). Dyspareunia, incontinence during sex, and fear of incontinence during sex each significantly improved after surgery. Preoperative urge incontinence was associated with abstinence after surgery (P = .02); postoperative urge incontinence negatively impacted sexual function (P = .047). CONCLUSION: Midurethral sling surgery for stress urinary incontinence significantly improves sexual function, although coexistent urge incontinence has a negative impact.
Journal Title: American Journal of Obstetrics and Gynecology
Volume: 207
Issue: 5
ISSN: 1097-6868; 0002-9378
Publisher: Unknown  
Journal Place: United States
Date Published: 2012
Start Page: 421.e1
End Page: 421.e6
Language: eng
DOI/URL:
Notes: LR: 20131119; CI: Copyright (c) 2012; GR: U01 DK058225/DK/NIDDK NIH HHS/United States; GR: U01 DK058229/DK/NIDDK NIH HHS/United States; GR: U01 DK058231/DK/NIDDK NIH HHS/United States; GR: U01 DK058234/DK/NIDDK NIH HHS/United States; GR: U01 DK060379/DK/NIDDK NIH HHS/United States; GR: U01 DK060380/DK/NIDDK NIH HHS/United States; GR: U01 DK060393/DK/NIDDK NIH HHS/United States; GR: U01 DK060395/DK/NIDDK NIH HHS/United States; GR: U01 DK060397/DK/NIDDK NIH HHS/United States; GR: U01 DK060401/DK/NIDDK NIH HHS/United States; GR: U01 DK58225/DK/NIDDK NIH HHS/United States; GR: U01 DK58229/DK/NIDDK NIH HHS/United States; GR: U01 DK58231/DK/NIDDK NIH HHS/United States; GR: U01 DK58234/DK/NIDDK NIH HHS/United States; GR: U01 DK60379/DK/NIDDK NIH HHS/United States; GR: U01 DK60380/DK/NIDDK NIH HHS/United States; GR: U01 DK60395/DK/NIDDK NIH HHS/United States; GR: U01 DK60397/DK/NIDDK NIH HHS/United States; GR: U01DK 60401/DK/NIDDK NIH HHS/United States; GR: U01DK60393/DK/NIDDK NIH HHS/United States; JID: 0370476; CIN: J Urol. 2013 Nov;190(5):1840. PMID: 24120804; NIHMS390429; OID: NLM: NIHMS390429; OID: NLM: PMC3562351; 2012/01/10 [received]; 2012/05/17 [revised]; 2012/06/27 [accepted]; 2012/06/29 [aheadofprint]; ppublish